Loading…
HEXI PREP is a brand name for Isopropyl Alcohol. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: The medicinal product is to be used for disinfection of the skin prior to invasive medical procedures that do not require a clean air environment.
Verbatim from this product's MHRA label. Tap a section to expand.
Posology HEXI PREP may be used on all age groups and patient populations. 4, Special warnings and precautions for use). 5mL or 3mL of the HEXI PREP alcoholic solution. Method of Administration For cutaneous use. 5mL (10 cm x 10cm) 10cm x 13cm • blood culture collection, • peripheral cannulation, • peripheral arterial line cannulation, • simple biopsy, • routine venepunctures • dialysis / fistula / graft site cleansing.
g. central line insertion), tear the sachet open and remove the impregnated pad with sterile tweezers onto a sterile tray. Contact with the outer face of the sachet by sterile gloves should be avoided as it is non-sterile. For both non-sterile and sterile procedures, the user should wear gloves during application.
Keep the impregnated pad folded and press firmly against the skin on the intended area and wipe back and forth for a total of 30 seconds. Allow to airdry completely. It is recommended that HEXI PREP solution remains on the skin post-procedure to provide continued antimicrobial activity.
If removal is necessary, remove with soap and water or alcohol
g. erythematous, papular, or maculopapular), pruritus and blisters or application site vesicles. Other local symptoms have included skin burning sensation, pain and inflammation. Frequency not known: dermatitis, eczema, urticaria, chemical burns in neonates.
4) The most commonly reported adverse reactions reported are associated with application site reactions. e. at the prep site) and very rarely spread. The adverse reactions were often self-limiting in nature or resolved following treatment with topical steroids and / or antihistamines.
The most commonly reported reactions were non-serious in nature and included application site rash, application site erythema, application site vesicles, application site pain and application site pruritus. Frequency, type and severity of adverse reactions in children are expected to be the same as in adults.
4). Description of selected adverse reactions There have been isolated spontaneous reports of generalised reactions potentially associated with solutions of chlorhexidine digluconate / isopropyl alcohol during anaesthesia. 4). This product may cause a severe allergic reaction.
Symptoms may include wheezing / difficulty breathing, shock, facial swelling, hives or rash. 3). If hypersensitivity or an allergic reaction occurs, stop use and seek medical help right away.
Reporting of suspected adverse reactions:
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows for continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
The solution is flammable. Do not use with electrocautery procedures or other ignition sources until dry. Remove any soaked materials, drapes or gowns before proceeding with the intervention. Do not allow the solution to pool in skin folds or under the patient or drip on sheets or other material in direct contact with the patient.
Where occlusive dressings are to be applied to areas previously exposed to HEXI PREP, care must be taken to ensure no excess product is present prior to application of the dressing For external use only on intact skin. HEXI PREP contains chlorhexidine.
Chlorhexidine is known to induce hypersensitivity, including generalised allergic reactions and anaphylactic shock. The prevalence of chlorhexidine hypersensitivity is not known, but available literature suggests this is likely to be very rare.
8). HEXI PREP must not come into contact with the eye. Serious cases of persistent corneal injury, potentially requiring corneal transplant, were reported following accidental ocular exposure to chlorhexidine containing medicinal products despite taking eye protective measures due to migration of solution beyond the intended surgical preparation area.
Extreme care must be taken during application to ensure that Hexiprep does not migrate beyond its intended application site into the eyes. Particular care should be taken in anaesthetised patients who are unable to immediately report ocular exposure.
If HEXI PREP comes into contact with the eyes, wash out promptly and thoroughly with water. An ophthalmologist’s advice should be sought. Do not use on open skin wounds. Do not use on broken or damaged skin. In addition, direct contact with neural tissue or the middle ear must be avoided.
Prolonged skin contact with alcoholic solutions should be avoided. 2 above). When the solution has been applied in an over-vigorous manner to very fragile or sensitive skin or after repeated use, local skin reaction may occur including erythema or inflammation, itching, dry and/or flaky skin and local application site pain.
The medicinal product is contra-indicated where patients have shown previous hypersensitivity to chlorhexidine or isopropyl alcohol
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Isopropyl Alcohol in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
At the first sign of local skin reaction application of HEXI PREP should be stopped. Anaphylactic reactions during anaesthesia Chlorhexidine-containing products are known causes of anaphylactic reactions during anaesthesia. g. a significant portion of skin may be covered or patient unable to communicate early symptoms.
g. abrupt fall in blood pressure, hives, angioedema), chlorhexidine-related allergic reactions should be considered. g. IV lines) should be removed. Special precaution should be taken to avoid patient exposure to any other product containing chlorhexidine during the course of the treatment Paediatric population The use of chlorhexidine solutions, both alcohol based and aqueous, for skin antisepsis prior to invasive medical procedures has been associated with chemical burns in neonates.
Based on available case reports and the published literature, this risk appears to be higher in preterm infants, especially those born before 32 weeks of gestation and within the first 2 weeks of life.